AbbVie is leveraging potential of immunotherapy for Alzheimer’s with a massive biotech deal
AbbVie- a renowned drug manufacturer from the U.S. is leveraging potential of immune system of a human body to combat Alzheimer’s by signing a medication development deal, which is valued at over US$ 200 million. The deal is signed with Alector, which is an unlisted biotech company in the United States. On Tuesday, the October 24, 2017, AbbVie stated that it will be paying US$ 205 million upfront and will be making a further US$ 20 million equity investment for working with Alector, for developing a new method of handling as well as curing Alzheimer’s – a chronic neurodegenerative disease that affects a person’s memory.
The idea of making use of immunotherapy for treating Alzheimer’s states how effective immune-oncology is in treating cancer, where the medications help the immune system of the patient to battle tumors. This method has revolutionized care practices for cancer patients. Scientists associated with Alector and AbbVie believe that there is an evidence that deficiencies in the immune system within the person’s central nervous system plays a vital role in the growth and progression of neurodegenerative diseases and disorders such as Alzheimer’s.
Chief executive of Alector, Arnon Rosenthal stated in an interview, “We are anticipating that immune-neurology treatments as well as therapies shall have as much as strong impact on brain disorders as immuno-oncology has on diseases like cancer.” The innovative research effort to treat Alzheimer’s has come against the backdrop of issues and failure, however; the progression of immune-based therapies is still at an early stage. As per the terms and conditions mentioned in the agreement, Alector and AbbVie have mutually agreed to study and research on a portfolio of certain antibody targets. AbbVie has an alternative on commercial rights and global development to two targets.
You may be interested
Widespread Use Of Insulin Pens Is Likely To Fuel The Growth Of The Disposable Insulin Pen MarketMohit Joshi - October 20, 2018
The Disposable Insulin Pen Market is expected to have a highly positive growth outlook from 2018-2026 according to a recently released by Coherent Market Insights, added in its…
Pulse Oximeter Market Is Also Driven By Technology Advancements And Also In Expansion Of Clinical ApplicationsMohit Joshi - October 20, 2018
The Pulse Oximeter Market is expected to have a highly positive growth outlook from 2018-2026 according to a recently released by Coherent Market Insights, added in its large…
Extracorporeal Shock Wave Lithotripsy Market Is Being Fuelled By Rise In Incidence Of Kidney StonesMohit Joshi - October 20, 2018
The Extracorporeal Shock Wave Lithotripsy Market is expected to have a highly positive growth outlook from 2018-2026 according to a recently released by Coherent Market Insights, added in…